3-(trans-4-{2-[4-(2,3-Dichlorophenyl)-1-piperazinyl]ethyl}cyclohexyl)-1,1-dimethylurea hydrochloride (1:1)(CAS: 1083076-69-0)

This compound falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous substances. It is also subject to the European Chemicals Agency (ECHA) REACH regulations. In the United States, it must comply with FDA and EPA requirements for chemical safety and environmental protection. Detailed handling and disposal guidelines are provided in the Safety Data Sheet (SDS).

Synthesis of this compound can be achieved using analogs such as 3-(trans-4-{2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl}cyclohexyl)-1,1-dimethylurea without the hydrochloride. Common alternative reagents include other piperazine derivatives and substituted cyclohexyl groups. However, the specific choice depends on the desired properties and the synthesis route.

The market for this compound is growing due to its applications in pharmaceuticals and agrochemicals. Research trends focus on optimizing synthesis processes and exploring its potential in treating various diseases. Market dynamics include increasing demand from the pharmaceutical industry and emerging research in novel drug design.

Waste containing this compound should be collected in appropriate containers and stored separately. Proper incineration or professional waste disposal services should be utilized to ensure compliance with environmental regulations. Precautions include personal protective equipment (PPE) and following local hazardous waste disposal guidelines.